If you suffered losses in SCYNEXIS stock, contact SCYNEXIS stock loss lawyer Timothy L. Miles about a SCYNEXIS class action lawsuit
Introduction to the THE SCYNEXIS CLASS ACTION LAWSUIT
The SCYNEXIS class action lawsuit seeks to represent purchasers or acquirers of SCYNEXIS, Inc. (NASDAQ: SCYX) securities between March 31, 2023 and September 22, 2023, inclusive (the “Class Period”). Captioned Feldman v. SCYNEXIS, Inc., No. 23-cv-22082 (D.N.J.), the SCYNEXIS class action lawsuit charges SCYNEXIS and certain of its top executive officers with violations of the Securities Exchange Act of 1934.
If you suffered losses in SCYNEXIS stock and wish to serve as lead plaintiff in the SCYNEXIS class action lawsuit, please contact SCYNEXIS Stock Loss Lawyer Timothy L. Miles by calling 855/846-6529 or via e-mail at [email protected] or by submitting a contact form. Lead plaintiff motions for the SCYNEXIS class action lawsuit must be filed with the court no later than January 8, 2024. In this resource center for shareholders, we will discuss all options shareholders have in the SCYNEXIS class action lawsuit, including moving to be appointed a lead plaintiff, doing nothing, timelines, and more. So, read on and learn everything you need to know about your options and your choices at this point in the litigation. the ALLEGATIONS IN THE SCYNEXIS CLASS ACTION LAWSUIT
The SCYNEXIS class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) the equipment used to manufacture ibrexafungerp was also used to manufacture a non-antibacterial beta-lactam drug substance, presenting a risk of cross-contamination; (ii) SCYNEXIS did not have effective internal controls and procedures, as well as adequate internal oversight policies to ensure that its vendor complied with current Good Manufacturing Practices; and (iii) due to the substantial risk of cross-contamination, SCYNEXIS was reasonably likely to recall its ibrexafungerp tablets and halt its clinical studies.
The SCYNEXIS class action lawsuit further alleges that on September 25, 2023, SCYNEXIS revealed that following a recent review by GSK plc of the manufacturing process and equipment at the vendor that manufactures the ibrexafungerp drug substance, SCYNEXIS became aware of potential cross contamination of ibrexafungerp with a non-antibacterial beta-lactam drug substance. SCYNEXIS declared it would conduct a recall of BREXAFEMME from the market and place a temporary hold on clinical studies of ibrexafungerp, including a Phase 3 clinical study, until a mitigation strategy and a resupply plan are determined, according to the complaint. The SCYNEXIS class action lawsuit alleges that on this news, the price of SCYNEXIS stock fell more than 41% over two trading sessions. THE LEAD PLAINTIFF DEADLINE IN THE SCYNEXIS CLASS ACTION LAWSUIT
The lead plaintiff deadline in the SCYNEXIS class action lawsuit is fast approaching, and investors who wish to participate in the case must act promptly. A securities class action lawsuit is a legal proceeding in which a group of investors who have suffered financial losses due to alleged fraudulent or misleading activities by a company join forces to seek compensation. In the case of SCYNEXIS, the pharmaceutical company is facing allegations of making false and misleading statements regarding the effectiveness and potential of one of its drug candidates as well as a lack of internal procedures, as well as adequate internal oversight policies to ensure that its vendor complied with current Good Manufacturing Practices. The lead plaintiff deadline is the date by which an investor must file a motion with the court to be appointed as the lead plaintiff in the class action lawsuit.
When a securities class action is filed such as the SCYNEXIS class action lawsuit, the person who files the first complaint is required to publish a notice announcing the filing. Anyone who wants to be lead plaintiff on behalf of the class in the SCYNEXIS class action lawsuit must thereafter file a motion to be appointed as lead plaintiff(s) no later than 60 days after the notice was published. Being appointed as the lead plaintiff in a securities class action lawsuit is an important role as it entails representing the interests of all the other investors who have suffered losses. The lead plaintiff is responsible for making key decisions throughout the litigation process, such as selecting legal counsel and negotiating settlements. It is crucial for investors who believe they have been affected by SCYNEXIS's alleged misconduct to consider participating in the class action lawsuit and potentially becoming the lead plaintiff. To be eligible for appointment as the lead plaintiff, investors must meet certain requirements, such as having suffered financial losses during the specified period and actively pursuing their legal rights. Investors need to consult with experienced securities litigation attorneys who can assess their claims and guide them through the process of filing a motion to be appointed as lead plaintiff. Time is of the essence, as missing the lead plaintiff deadline could result in losing the opportunity to participate in the lawsuit and seek potential compensation for their losses. In conclusion, investors who have been affected by SCYNEXIS's alleged fraudulent activities should be aware of the approaching lead plaintiff deadline in the class action lawsuit. By taking prompt action and seeking legal representation, investors can potentially participate in the litigation process and have a voice in seeking justice and compensation for their losses. Remember, lead plaintiff motions for the SCYNEXIS class action lawsuit must be filed with the court no later than January 8, 2024. Your options if you receive a notice in the SCYNEXIS CLASS ACTION LAWSUIT
If you have received a notice in a securities class action, such as the SCYNEXIS class action lawsuit, it is important to understand your options and what steps you can take. First, it is crucial to carefully read the notice and understand the allegations being made in the lawsuit. This will allow you to evaluate whether or not you have a valid claim and if it is worth pursuing.
Once you have reviewed the notice and determined that you may have a valid claim, you have a few options. The first option is to do nothing and remain a passive member of the class action. By doing so, you may be eligible to receive compensation if the lawsuit is successful and a settlement or judgment is reached. However, it is important to note that your recovery may be limited depending on the size of the class and the damages awarded. Alternatively, you can choose to opt out of the class action. By opting out, you are removing yourself from the lawsuit and preserving your right to pursue an individual claim against the defendant. This option may be beneficial if you believe that your losses are significant and that you would be better served by pursuing your own legal action. Another option is to participate actively in the class action as a lead plaintiff. This involves taking on a leadership role in the lawsuit and representing the interests of the class members. As a lead plaintiff, you may have greater control over the litigation process and potentially increase your chances of obtaining a favorable outcome. Note, that if you opt out, you will not be able to participate in any settlement or recovery obtained in the SCYNEXIS class action lawsuit. Regardless of which option you choose, it is highly recommended to consult with an attorney who practices securities litigation. They can guide the best course of action based on your circumstances and ensure that your rights are protected throughout the legal process. IF YOU RECEIVE A SETTLEMENT FROM FINRA YOU CAN STILL PARTICIPATE IN THE SCYNEXIS LAWSUIT LAWSUIT
In the realm of financial regulations, the acceptance of restitution or compensation from a FINRA regulatory settlement does not, in any way, waive an individual's right to pursue further monetary or other benefits through the courts. This is true even in cases involving class action lawsuits, such as the recent SCYNEXIS class action lawsuit.
When individuals or entities are affected by fraudulent activities or misconduct within the financial industry, they may choose to participate in a class action lawsuit to seek justice and compensation. However, it is important to note that the acceptance of restitution or compensation from a regulatory settlement, such as one facilitated by FINRA, does not prevent individuals from pursuing additional legal remedies through the court system. The purpose of a regulatory settlement is to address and resolve violations of financial regulations, often resulting in restitution or compensation for affected parties. While accepting such restitution or compensation may provide some form of redress, it does not foreclose the possibility of seeking further remedies through the courts. This is because regulatory settlements focus on resolving specific regulatory violations, whereas court proceedings can address a broader range of legal claims and seek additional forms of relief. In the case of the SCYNEXIS class action lawsuit, individuals who have accepted restitution or compensation from a FINRA regulatory settlement are still entitled to pursue their claims in court if they believe they are owed further monetary or other benefits. The acceptance of restitution or compensation from a regulatory settlement is separate from any potential legal action in the court system. Therefore, individuals should consult with legal counsel to determine their options and rights regarding pursuing additional benefits through the courts. YOU HAVE THE OPTION TO MOVE FOR LEAD PLAINTIFF IN THE SCYNEXIS CLASS ACTION LAWSUIT
The lead plaintiff process under the Private Securities Litigation Reform Act of 1995, is a crucial aspect of class action lawsuits such as the SCYNEXIS class action lawsuit. The PSLRA was enacted in 1995 with the aim of promoting fairness and efficiency in securities fraud litigation. One of the key provisions of the PSLRA is the requirement for the appointment of a lead plaintiff in class action lawsuits.
The lead plaintiff is typically a shareholder who is willing to actively participate in the litigation and represent the interests of all class members. The PSLRA establishes a rigorous process for selecting the lead plaintiff to ensure that the most suitable candidate is chosen. Potential lead plaintiffs must file a motion with the court, providing detailed information about their financial interest in the lawsuit, their experience in similar litigation, and any potential conflicts of interest. Once the motions for lead plaintiff are filed, the court will evaluate and consider various factors in making its decision. These factors may include the size of the plaintiff's financial interest, their litigation experience, their understanding of the case, and their ability to adequately represent the class. The court may also consider any potential conflicts of interest that could impair a plaintiff's ability to fairly represent the class. The lead plaintiff plays a crucial role in the class action lawsuit. They will work closely with their legal team to develop and execute a litigation strategy, gather evidence, and represent the interests of all class members. The lead plaintiff also has the responsibility to keep other class members informed about the progress of the case and seek their input when necessary. In conclusion, the lead plaintiff process under the PSLRA is an important aspect of class action lawsuits such as the SCYNEXIS class action lawsuit. It ensures that a qualified and suitable representative is chosen to protect the interests of all class members and promotes fairness and efficiency in securities fraud litigation. THE BENEFITS OF SERVING AS LEAD PLAINTIFF IN THE SCYNEXIS CLASS ACTION LAWSUIT
Serving as a Lead Plaintiff in the SCYNEXIS class action lawsuit has several advantages and important benefits including:
Thus, there are numerous benefits and other advantages to serving as lead plaintiff in a class action against SCYNEXIS if you suffered losses in SCYNEXIS stock. your responsibilities if you decide to move for lead plaintiff in the SCYNEXIS CLASS ACTION LAWSUIT
A Lead Plaintiff owes a fiduciary duty to the class, and therefore, must act in the best interest of the class in the SCYNEXIS class action lawsuit. Some of the responsibilities of the Lead Plaintiff in the SCYNEXIS class action lawsuit include:
you cannot BE APPOINTED LEAD PLAINTIFF IN THE SCYNEXIS CLASS ACTION LAWSUIT IF I PURCHASED SHARES OUTSIDE OF THE CLASS PERIOD
Even if you suffered losses in SCYNEXIS stock, if you purchased securities outside of the Class period, you will not be able to participate in the SCYNEXIS class action lawsuit.
YOU CAN BE A LEAD PLAINTIFF IN THE SCYNEXIS CLASS ACTION LAWSUIT IF YOU ARE A LEAD PLAINTIFF IN ANOTHER CASE
Unless you have been a lead plaintiff in more than five securities class actions during any three-year period which is expressly prohibited by the securities laws. Otherwise, if you suffered losses in SCYNEXIS stock, you may move to be appointed lead plaintiff in the SCYNEXIS class action lawsuit.
YOU CAN SELL YOUR STOCK AND STILL BE A MEMBER OF THE CLASS IN THE SCYNEXIS CLASS ACTION LAWSUIT
In a securities fraud class action lawsuit such as the SCYNEXIS class action lawsuit, it is possible to sell your stock after the class period and still be a member of the class. Class actions are legal proceedings brought by a group of individuals who have suffered similar harm due to the actions of a defendant. In this case, investors who purchased SCYNEXIS stock during a certain period of time may be eligible to join the class action and seek compensation for any losses they incurred.
The class period is typically defined as the time frame during which the alleged fraudulent activity took place. It is important for investors to be aware of this period and ensure that their purchases fall within it in order to be eligible for participation in the class action. However, selling the stock after the class period does not necessarily disqualify an investor from being a member of the class if they suffered losses. The purpose of a securities fraud class action is to provide a collective remedy for all affected investors, regardless of whether they still hold the stock at the time the lawsuit is filed or settled. Selling the stock after the class period may impact the amount of potential damages that an investor can recover, as it is typically based on the difference between the purchase price and the stock's value at a certain point in time. However, it does not exclude an investor from being part of the class and seeking compensation for any losses suffered during the class period. It is important for investors who believe they may have a claim in a securities fraud class action, such as the SCYNEXIS class action lawsuit, to consult with an experienced securities litigation attorney. They can provide guidance on eligibility requirements, potential damages, and the overall process of participating in the class action. By doing so, investors can protect their rights and potentially recover any losses incurred due to fraudulent activity. In summary, there is no requirement for you to retain ownership of the stock after the class period has expired to participate in the SCYNEXIS class action lawsuit. HOW A SCYNEXIS STOCK LOSS LAWYER CAN HELP you
A SCYNEXIS stock loss Lawyer is well-versed in the complex laws that govern the securities industry and litigation and focuses on representing individual investors or funds who have been the victims of fraud or who have disputes with investment professionals. Ordinary individual investors, including civil servants, teachers, nurses, and retirees, may need a securities lawyer. In most cases, they have lost money due to mistakes, incompetence, or fraud by an investment professional.
While FINRA, the SEC, and state securities regulators serve a vital role in protecting investors, they simply have too many individuals, firms, and market transactions to monitor to discover every act of fraud or negligence. Individual investors should consult with a securities lawyer if they have lost money due to fraud or stockbroker misconduct. Look for a securities lawyer with experience, high ethical standards, verifiable credentials, and a trustworthy reputation among his peers and the judiciary, as well as testimonials from previous clients and awards and recognitions. One name that immediately pops up is nationally known and widely respected Nashville lawyer Timothy L. Miles, who has valuable experience and has received numerous awards, mostly due to his high ethical standards, and hard work ethic, including most recently being named a Top 25 Class action lawyer by the National Trial Lawyers Association, and has maintained an AV rating from Martindale-Hubble since 2014, was named a 2023 Top Rated Litigator and 2023 Top Rated Lawyer by Martindale-Hubble and ALM, and was recently named a 2023 Elite Lawyer of the South by Martindale-Hubble for the fifth year in a row, and was a recipient of Avvo Client’s Choice Award in 2021, in 2022 was featured in the Top 100 Lawyers Magazine and received the Lifetime Achievement Award by Premier Lawyers of America (2019–2021). This will most likely be the only call you need to make. (855) 846–6529 or [email protected]. HOW TO KNOW IF YOU ARE A MEMBER OF THE CLASS IN THE SCYNEXIS LAWSUIT
If you purchased shares during the class period and suffered losses in SCYNEXIS stock, then you are most likely a member of the class in the SCYNEXIS class action lawsuit and may participate in the SCYNEXIS class action lawsuit since you suffered losses in SCYNEXISstock.
YOU HAVE THE OPTION OF EXCLUDING YOURSELF IN THE SCYNEXIS CLASS ACTION LAWSUIT
Objecting is telling the Court you do not believe the settlement in the SCYNEXIS class action lawsuit, or some part of it, is fair or reasonable. You can file an objection only if you stay in the Class and do not exclude yourself, and you may submit a Claim Form even if you object to the settlement. On the other hand, requesting exclusion is explicitly telling the Court you do not want to be part of the Class or the Settlement in the class action against SCYNEXIS. If you exclude yourself, you cannot object to the Settlement because you no longer have standing as you are not a class member anymore. Similarly, you cannot submit a Claim Form. If you stay in the Class and object, but your objection is overruled, you will not be allowed a second opportunity to exclude yourself.
YOU HAVE THE OPTION OF HIRING A SCYNEXIS STOCK LOSS LAWYER IF YOU SUFFERED LOSSES IN SCYNEXIS STOCK AT NO COST
If you suffered losses in SCYNEXIS and are a member of the class, it does not cost anything to hire a SCYNEXIS stock loss lawyer. Our firm litigates securities fraud cases on a contingent fee basis, so plaintiffs and the class do not pay attorneys’ fees or court costs unless there is a recovery, and the attorney fees and costs are awarded by the court as a percentage of the total recovery for the class. So, contact a SCYNEXIS stock loss lawyer today if you suffered losses in SCYNEXIS stock about a SCYNEXIS class action lawsuit.
CONTACT A SCYNEXIS STOCK LOSS LAWYER TODAY IF YOU SUFFERED LOSSES IN SCYNEXIS STOCK ABOUT A SCYNEXIS CLASS ACTION LAWSUIT
If you suffered losses in SCYNEXIS stock, contact SCYNEXIS stock loss lawyer Timothy L. Miles today for a free case evaluation about a SCYNEXIS class action lawsuit. Call today and see what a SCYNEXIS stock loss lawyer could do for you if you suffered losses in SCYNEXIS stock.
SCYNEXIS stock loss lawyer Timothy L. MilesNashville attorney Timothy L. Miles is a nationally recognized shareholder rights attorney raised in Nashville, Tennessee. Mr. Miles has dedicated his career to representing shareholders, employees, and consumers in complex class-action litigation. Whether serving as lead, co-lead, or liaison counsel, Mr. Miles has helped recover hundreds of millions of dollars for defrauded investors, shaped precedent-setting decisions, and delivered real corporate governance reforms. Judges and peers have repeatedly recognized Mr. Miles’ relentless advocacy for the underdog, as well as his unbendable ethical standards. Mr. Miles was recently selected by Martindale-Hubbell® and ALM as a 2022 Top Ranked Lawyer, 2022 Top Rated Litigator. and a 2022 Elite Lawyer ofthe South. Mr. Miles also maintains the AV Preeminent Rating by Martindale-Hubbell®, their highest rating for both legal ability and ethics. Mr. Miles is a member of the prestigious Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association,Class Action: Class Action: Top National Trial Lawyers, National Trial Lawyers Association (2023), a superb rated attorney by Avvo, a recipient of the Lifetime Achievement Award by Premier Lawyers of America (2019) and recognized as a Distinguished Lawyer, Recognizing Excellence in Securities Law, by Lawyers of Distinction (2019); a Top Rated Litigator by Martindale-Hubbell® and ALM (2019-2022); America’s Most Honored Lawyers 2020 – Top 1% by America’s Most Honored (2020-2022). Mr. Miles has published over sixty articles on various issues of the law, including class actions, whistleblower cases, products liability, civil procedure, derivative actions, corporate takeover litigation, corporate formation, mass torts, dangerous drugs, and more. Please visit our website or call for free anytime. Comments are closed.
|
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
July 2024
Categories
All
|
CONTACT
The Law Offices of Timothy L. Miles Tapestry at Brentwood Town Center 300 Centerview Dr., #247 Brentwood, TN 37027 Phone: (855) 846-6529 Email: [email protected] HOURS OF OPERATION Mon-Fri: 24/7 Sat-Sun: 24/7 |